US › Healthcare

Marpai Inc (MRAI)

US · Healthcare · Healthcare Plans

—

Latest quarter · ended 2026-06-30

Revenue

$4.2M

Revenue YoY

-10.5%

Net profit

$-4.6M

Profit YoY

-4.9%

EPS

$-0.20

EPS estimate

$-0.10

Net margin

-110.0%

EPS came in at -0.20 against a street estimate of -0.10 — a miss of 100.0%.

Key statistics

Market cap

$62.5M

Forward P/E

0.0

P/B

1.49

Book value

$-1.39

EPS (TTM)

$-25.20

52-week high

$2.50

52-week low

$0.21

50-day MA

$1.46

200-day MA

$0.80

Beta

4.73

Analyst view

Analysts rate Marpai Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $6.00.

Shareholding

Insiders

51.09%

Institutions

3.84%

Largest institutional holders

Fund	Stake
FNY Investment Advisers, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Marpai Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.